Loading stock analysis…
Evidence Synthesis
Last synthesized: 11 Jul 2026, 06:07
Evidence Synthesis
LALPATHLAB has experienced a significant shift in its financial performance.
The gross margin has accelerated, increasing from 20.95%. This improvement in gross margin is a positive development for the company.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 59.49 % | 20.95 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 20.95 % | 18.27 | ▲ |
| REVENUE_GROWTH_YOY | 16.6 % | -15.4 | ▲ |
| EPS_ACTUAL | 7.925 INR | 9.005 | ▼ |
| EPS_SURPRISE_PERCENT | 0.107 % | -0.004 | ▲ |
| PRICE_CHANGE_PERCENT | 1.881 % | — | - |
| DAILY_VOLUME | 2,53,652 shares | 6,32,782 | ▼ |
| CLOSE_PRICE | 1,684.6 INR | 1,653.5 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.73 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 5 count | 17 | ▼ |
| TARGET_PRICE_PREMIUM | 0.08 % | — | - |